However, a study demonstrates the modulation of zinc treatment resistance for PCa, which includes, among various factors, HIF-1α expression, but mainly the activation of the KRAS/PI3K/NF-kB pathway [136]. The gene discussed is HIF1A; the disease is posterior cortical atrophy.